Please click on "Buy Now" to obtain the white paper on "21st Century Cures Initiative Leads the Way For Change: Five Regulatory Issues You Need to Know About"
“21st Century Cures Initiative” is poised to dramatically alter the way pharmaceutical and medical device products are developed and marketed in the US. The initiative pushes to reform and expedite the discovery, development and delivery of drugs and devices.
If enacted, the 21st Century Cures Act will drive drastic regulatory and policy changes within the pharmaceutical industry. This has pushed regulatory leaders to consider how their organizations should alter their operations to accommodate the regulatory changes contained in the bill.
This white paper from Best Practices, LLC addresses the five regulatory issues that carry the most implications and also have the greatest chance of being enacted into law.